US Approves First Pill with Digital Tracking Device

The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them.

The drug Abilify MyCite, developed by Otsuka Pharmaceutical Co. Ltd, was first approved by the FDA in 2002 to treat schizophrenia. The ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012.

News In-a-Line:
Food and Drug Administration (FDA)- approved 1st drug in the United States with a digital ingestion tracking system- named Abilify MyCite– developed by Otsuka Pharmaceutical Co. Ltd.
Static/Current Takeaway Points Important for IBPS PO Mains 2017 Exam-
  1. US President- Donald Trump (45th)

Source- The Hindu

×

Download success!

Thanks for downloading the guide. For similar guides, free study material, quizzes, videos and job alerts you can download the Adda247 app from play store.

[adda247_lead_form]

Leave a comment

Your email address will not be published. Required fields are marked *